Certain types of life science research involving “high consequence pathogens and toxins” would be subject to new review and risk mitigation procedures which might include classification of the research or termination of the funding, according to a U.S. government policy issued yesterday by the National Institutes of Health.
The policy applies to research involving 15 specified biological agents and toxins which “pose the greatest risks of deliberate misuse with most significant potential for mass casualties or devastating effects to the economy, critical infrastructure or public confidence.”
Research that increases the lethality or transmissibility of the agent or toxin, or otherwise enhances its harmful consequences, will be subject to the new review procedures.
Based on the outcome of the review, a risk mitigation plan may be developed. If less restrictive measures were deemed inadequate, the new policy would allow for national security classification of the research or termination of government funding.
See “United States Government Policy for Oversight of Life Sciences Dual Use Research of Concern,” March 29, 2012.
See also “U.S. Requires New Dual-Use Biological Research Reviews” by David Malakoff, Science Insider, March 29.
This runs counter to public opinion: 4 in 5 of all Americans, across party lines, want to see the government take stronger climate action.
Remaining globally competitive on critical clean technologies requires far more than pointing out that individual electric cars and rooftop solar panels might produce consumer savings.
The American administrative state, since its modern creation out of the New Deal and the post-WWII order, has proven that it can do great things. But it needs some reinvention first.
The Federation of American Scientists supports Congress’ ongoing bipartisan efforts to strengthen U.S. leadership with respect to outer space activities.